معرفی
Dr. Philip R. Holland is a Reader in Neuroscience at King's College London, affiliated with the Wolfson Sensory, Pain and Regeneration Centre within the School of Neuroscience and the Institute of Psychiatry, Psychology & Neuroscience. His research focuses on understanding migraine mechanisms and developing therapies, with a particular emphasis on neurovascular interactions and pain pathways. He leads a team funded by organizations like the Medical Research Council, Wellcome Trust, and European Research Council. Dr. Holland earned his PhD under Prof. Peter Goadsby at University College London, followed by postdoctoral research at UCSF and the University of Edinburgh. He actively engages in teaching, public awareness, and editorial roles (e.g., Cephalalgia). Key awards include the 2020 Medical Research Foundation Emerging Leaders Prize. His work spans clinical and translational research, aiming to bridge basic science with patient care.
Education: PhD in Neuroscience, Postgraduate Certificate in Academic Practice (King's College London). External Roles: External Examiner at UCL, Science Editor of CGRP Forum, Associate Editor of Cephalalgia. Grants/Projects: Investigates trigeminal autonomic cephalalgias, neuroendocrine signaling, and novel therapies like cannabidiol combinations. Labs/Teams: Leads a migraine-focused research group exploring neurobiological and pharmacological interventions.
